Vitamin D Insufficiency Linked to Paclitaxel-Induced Neuropathy
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 8, 2023 -- Pretreatment vitamin D insufficiency is associated with an increased incidence of grade ≥3 chemotherapy-induced peripheral neuropathy (CIPN) from paclitaxel, according to a study published in the November issue of the Journal of the National Comprehensive Cancer Network.
Ciao-Sin Chen, Pharm.D., Ph.D., from the University of Michigan College of Pharmacy in Ann Arbor, and colleagues used data and samples from the prospective phase III SWOG S0221 trial that compared paclitaxel-containing chemotherapy regimens for early-stage breast cancer to validate vitamin D insufficiency as a CIPN risk factor. The association between vitamin D insufficiency (≤20 ng/mL) and grade ≥3 sensory CIPN was examined and adjusted for self-reported race, age, body mass index, and paclitaxel schedule.
Overall, 33.3 percent of the 1,191 female participants in the analysis had pretreatment vitamin D insufficiency and 16.4 percent developed grade ≥3 CIPN. The researchers found that the incidence of grade ≥3 CIPN was higher for patients with vitamin D insufficiency versus those with sufficient vitamin D (20.7 versus 14.2 percent; odds ratio, 1.57). After adjustment for age and paclitaxel schedule, the association retained significance (adjusted odds ratio, 1.65), but it did not after adjustment for race. In mouse experiments designed to test the direct effect of vitamin D deficiency, a vitamin D-deficient diet caused mechanical hypersensitivity and sensitized mice to paclitaxel.
"Vitamin D insufficiency may be a clinically useful biomarker to inform personalized supplementation to reduce CIPN occurrence, improve long-term quality of life, and perhaps enable patients to remain on effective paclitaxel treatment and improve survival," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Distal Symmetric Polyneuropathy Often Undiagnosed
WEDNESDAY, May 8, 2024 -- Distal symmetric polyneuropathy (DSP) is common and is frequently undiagnosed, according to a study published online May 8 in Neurology. Melissa A...
Probiotic, Vitamin D Supplementation Tied to Benefits With Schizophrenia
FRIDAY, April 12, 2024 -- Supplementation with probiotics and vitamin D may have beneficial effects on cognitive function in patients with schizophrenia, according to a study...
Aerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms
WEDNESDAY, Aug. 2, 2023 -- A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.